Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Eissa A. Jafari
Observed name:
Eissa Jafari
Institutions:
University of Florida Health,
University of Florida,
Jazan University
Observed institutions:
University of Georgia,
Augusta University,
Charlie Norwood VA Medical Center,
University of Florida Health,
University of Florida,
Jazan University
show all 6
ORCID:
0009-0003-4463-5921
Observed ORCID:
0009-0003-4463-5921
OpenAlex ID:
A5009162190
Acrolein: A Potential Mediator of Oxidative Damage in Diabetic Retinopathy
2020
·
Moaddey Alfarhan
, Eissa Jafari
, et al.
·
Biomolecules
·
69
PDF
Characteristics and Predictors of Apparent Treatment-Resistant Hypertension in Real-World Populations Using Electronic Health Record-Based Data
2023
·
Eissa Jafari
, Rhonda M Cooper-DeHoff
, et al.
·
American Journal of Hypertension
·
21
PDF
Using electronic health records for clinical pharmacology research: Challenges and considerations
2024
·
Eissa Jafari
, Marisa H. Blackman
, et al.
·
Clinical and Translational Science
·
18
PDF
Spermine oxidase inhibitor, MDL 72527, reduced neovascularization, vascular permeability, and acrolein-conjugated proteins in a mouse model of ischemic retinopathy
2024
·
Abdullah Alhumaid
, Fang Liu
, et al.
·
Tissue Barriers
·
7
PDF
Characterizing apparent treatment resistant hypertension in the United States: insights from the All of Us Research Program
2024
·
Mona Alshahawey
, Eissa Jafari
, et al.
·
Journal of the American Medical Informatics Association
·
6
PDF
Impact of the 2017 ACC/AHA hypertension guidelines on antihypertensive prescribing in the United States: real-world evidence from a nationally representative population
2026
·
Eissa A. Jafari
·
Frontiers in Pharmacology
·
3
PDF
Racial/Ethnic Disparities in Use of Angiotensin II Receptor Type 2/4 Stimulatory Vs. Inhibitory Antihypertensive Among Hypertensive Adults in the USA
2024
·
Eissa Jafari
, Sumaya Abuloha
, et al.
·
Journal of Racial and Ethnic Health Disparities
·
3
Fixed-dose combination antihypertensive therapy and healthcare utilization in U.S. adults with hypertension: a propensity score–based analysis of a nationally representative population
2026
·
Eissa A. Jafari
·
Frontiers in Pharmacology
·
2
PDF
Characterizing Alzheimer’s Disease and Related Dementia in a Hypertension Population Within the State of Florida Using Electronic Health Record–Based Data
2025
·
Eissa A. Jafari
, Mona Alshahawey
, et al.
·
Clinical Pharmacology & Therapeutics
·
2
C-Reactive Protein-to-Albumin Ratio as a Prognostic Marker in ICU Patients with Pre-Existing Hypertension and Diabetes
2026
·
Sultan Almuntashiri
, Eissa A. Jafari
, et al.
·
Journal of Clinical Medicine
·
1
PDF
Age-range dependence and prediction compression in blood-based chronological-age models
2026
·
Ali Hanbashi
, El Mahdi Khribch
, et al.
·
BMC Medical Informatics and Decision Making
Fixed-dose combination versus multi-pill combination antihypertensive therapy in medication-defined apparent treatment-resistant hypertension: real-world evidence on healthcare utilization and health-related quality of life
2026
·
Eissa A. Jafari
·
Frontiers in Pharmacology
PDF
Hypertension among Middle Eastern and North African adults residing in the United States: addressing equity in health research representation using the All of Us Research Program, 2000–2024
2026
·
Eissa A. Jafari
·
Frontiers in Medicine
PDF
Survival Assessment by Central Review vs. Local Investigator in Metastatic Melanoma: A Systematic Review and Meta-Analysis
2026
·
Islam Eljilany
, Eissa Jafari
, et al.
·
Cancers
PDF
Progression-free survival (PFS) assessment by blinded independent central review (BICR) versus local investigator (LI) in metastatic melanoma (MM) randomized controlled trials (RCT): A systematic review and meta-analysis.
2025
·
Islam Eljilany
, Eissa Jafari
, et al.
·
Journal of Clinical Oncology
PDF
Show more works
View as search
Works count:
15
Citation count:
132
H-index:
5
I10-index:
3
Year
Topic
Type